Hermelo, Ismaïl
Haapala, Ilkka
Mäkelä, Meri
Jacome Sanz, Dafne
Kontunen, Anton
Karjalainen, Markus
Müller, Philipp
Lehtimäki, Kai
Nykter, Matti
Frösén, Juhana
Haapasalo, Hannu
Roine, Antti
Oksala, Niku
Nordfors, Kristiina
Vehkaoja, Antti
Haapasalo, Joonas
Funding for this research was provided by:
Research Council of Finland (360768)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
Finnish Pediatric Research Foundation
Lasten Syöpäsäätiö Väreen
The Finnish Ministry of Social Affairs and Health
Emil Aaltosen Säätiö
Tampere University Foundation Trust
Tampere University
Article History
Received: 7 October 2024
Accepted: 13 November 2024
First Online: 23 November 2024
Declarations
:
: Industry affiliation (Olfactomics Ltd., Tampere, Finland): Meri Mäkelä MSc., Anton Kontunen Ph.D., Markus Karjalainen Ph.D., Antti Roine Ph.D. and Niku Oksala M.D., Ph.D.. The rest of the authors have no conflicts of interests to declare. The rest of the authors have no conflicts of interests or non-financial interests to disclose.
: The study was performed following the principles of the Declaration of Helsinki. This prospective study was reviewed and approved by The Regional Ethics Committee of Tampere University Hospital (Tampere, Finland), with the approval number: R14024 (date 31.3.2014).
: All patients provided informed consent to participate in the study.
: “Not applicable”.